TY - JOUR
T1 - Evolution of imaging in rectal cancer
T2 - Multimodality imaging with MDCT, MRI, and PET
AU - Raman, Siva P.
AU - Chen, Yifei
AU - Fishman, Elliot K
PY - 2015
Y1 - 2015
N2 - Magnetic resonance imaging (MRI), multidetector computed tomography (MDCT), and positron emission tomography (PET) are complementary imaging modalities in the preoperative staging of patients with rectal cancer, and each offers their own individual strengths and weaknesses. MRI is the best available radiologic modality for the local staging of rectal cancers, and can play an important role in accurately distinguishing which patients should receive preoperative chemoradiation prior to total mesorectal excision. Alternatively, both MDCT and PET are considered primary modalities when performing preoperative distant staging, but are limited in their ability to locally stage rectal malignancies. This review details the role of each of these three modalities in rectal cancer staging, and how the three imaging modalities can be used in conjunction.
AB - Magnetic resonance imaging (MRI), multidetector computed tomography (MDCT), and positron emission tomography (PET) are complementary imaging modalities in the preoperative staging of patients with rectal cancer, and each offers their own individual strengths and weaknesses. MRI is the best available radiologic modality for the local staging of rectal cancers, and can play an important role in accurately distinguishing which patients should receive preoperative chemoradiation prior to total mesorectal excision. Alternatively, both MDCT and PET are considered primary modalities when performing preoperative distant staging, but are limited in their ability to locally stage rectal malignancies. This review details the role of each of these three modalities in rectal cancer staging, and how the three imaging modalities can be used in conjunction.
KW - computed tomography (CT)
KW - magnetic resonance imaging (MRI)
KW - positron emission tomography (PET)
KW - Rectal cancer
KW - staging
UR - http://www.scopus.com/inward/record.url?scp=84995794051&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995794051&partnerID=8YFLogxK
U2 - 10.3978/j.issn.2078-6891.2014.108
DO - 10.3978/j.issn.2078-6891.2014.108
M3 - Article
C2 - 25830037
AN - SCOPUS:84995794051
SN - 2078-6891
VL - 6
SP - 172
EP - 184
JO - Journal of Gastrointestinal Oncology
JF - Journal of Gastrointestinal Oncology
IS - 2
ER -